(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

WVU medicine is conducting a trial to combat weight gain after patients stop taking GLP-1 drugs such as Ozempic. Officials ...

Confidence among U.S. consumers weakened for a second-straight month, reflecting retreating optimism of both current and future conditions at the start of President Trump’s second term and ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Duane Mellor a member of the British Dietetic Association. He has in the past undertaken advisory and consultative work with the soft drinks, sweetener and sugar industry. For years it has been ...

The world’s top 500 wealthiest individuals faced a combined loss of $108 billion due to a tech-led selloff initiated by Chinese AI developer DeepSeek. Nvidia's Jensen Huang lost $20.1 billion. The ...

Why Trust Us? It’s been a hotly debated topic for years: Is focusing on your diet or your workout regimen better when you're trying to lose weight? While research over time has generally found ...

Weight loss injections are prescription medications to help with weight loss. They can help alter a person’s appetite and metabolism, curbing hunger and reducing calorie intake. Weight loss ...